Northern Trust’s Jade Biosciences, Inc. Common Stock JBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.28M | Buy |
228,092
+224,972
| +7,211% | +$2.25M | ﹤0.01% | 2914 |
|
|
2025
Q1 | $274K | Buy |
3,120
+72
| +2% | +$6.33K | ﹤0.01% | 3825 |
|
|
2024
Q4 | $283K | Buy |
3,048
+180
| +6% | +$16.7K | ﹤0.01% | 3869 |
|
|
2024
Q3 | $210K | Buy |
2,868
+133
| +5% | +$9.73K | ﹤0.01% | 3870 |
|
|
2024
Q2 | $159K | Sell |
2,735
-81
| -3% | -$4.71K | ﹤0.01% | 3929 |
|
|
2024
Q1 | $2.91M | Sell |
2,816
-28
| -1% | -$29K | ﹤0.01% | 2772 |
|
|
2023
Q4 | $2.25M | Sell |
2,844
-312
| -10% | -$247K | ﹤0.01% | 2932 |
|
|
2023
Q3 | $1.5M | Buy |
3,156
+642
| +26% | +$305K | ﹤0.01% | 3090 |
|
|
2023
Q2 | $1.51M | Buy |
2,514
+301
| +14% | +$181K | ﹤0.01% | 3177 |
|
|
2023
Q1 | $1.56M | Sell |
2,213
-21
| -0.9% | -$14.8K | ﹤0.01% | 3048 |
|
|
2022
Q4 | $2.29M | Buy |
2,234
+96
| +4% | +$98.5K | ﹤0.01% | 2931 |
|
|
2022
Q3 | $1.24M | Sell |
2,138
-37
| -2% | -$21.5K | ﹤0.01% | 3240 |
|
|
2022
Q2 | $1.19M | Sell |
2,175
-809
| -27% | -$443K | ﹤0.01% | 3298 |
|
|
2022
Q1 | $1.92M | Buy |
2,984
+493
| +20% | +$316K | ﹤0.01% | 3125 |
|
|
2021
Q4 | $1.03M | Sell |
2,491
-29
| -1% | -$12K | ﹤0.01% | 3533 |
|
|
2021
Q3 | $1.85M | Buy |
+2,520
| New | +$1.85M | ﹤0.01% | 3331 |
|